The U.S. Patent and Trademark Office’s (USPTO) updated guidelines, issued on July 17, 2023, aim to clarify the eligibility of AI-related patent claims under 35 U.S.C. § 101 for both examiners and stakeholders. This new guidance is particularly focused on the application of the two-step Alice/Mayo test to determine if a claim involves an abstract idea and whether it represents a practical application.
The update incorporates examples illustrating how the USPTO currently interprets the eligibility criteria. For instance, Example 47 discusses the eligibility of an AI-based anomaly detection system. This example demonstrates that claims specifying a physical device with definite hardware components or applying an abstract idea to a particular technological improvement are more likely to be considered eligible. Claims directed purely to AI processes or models without a specified application on technology can risk being deemed ineligible.
Another illustration, Example 48, highlights AI-based speech signal processing. Detailed technical descriptions of AI models, their training, and their application can transform an otherwise abstract claim into an eligible one. This underscores the importance of elaborating on the specific structure and function of AI technologies to meet eligibility requirements.
Similarly, Example 49 focuses on AI-assisted personalized medical treatment. Claims that include specific technical implementations or integrate medical AI models in practical applications with meaningful limitations stand a better chance of being considered eligible.
In essence, while these updated guidelines and examples from the USPTO offer a framework for drafting eligible AI-related claims, they also underline that substantial technical detail and clear demonstrations of technological improvement are essential. The true effectiveness of these guidelines will become evident in how future patent applications are adjudicated and whether they can meet these nuanced requirements for eligibility.